Segment Information and Concentration (Tables)

9 Months Ended

Sep. 30, 2024

Segment Information and Concentration

Schedule Of Segment Information

Three Months Ended September 30, 2024:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,316,600	$	452,500		$	-		$	2,769,100
Foreign Sales		562,000		241,900						803,900
Income (Loss) From Operations		258,700		(1,200,000	)		(317,300	)		(1,258,600	)
Assets		6,114,600		4,697,900			2,464,300			13,306,800
Long-Lived Asset Expenditures		2,900		900			-			3,800
Depreciation and Amortization		21,900		166,200			-			188,100

Three Months Ended September 30, 2023:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	2,161,300	$	424,200		$	-		$	2,585,500
Foreign Sales		625,000		242,900						867,900
Income (Loss) From Operations		73,600		(2,105,500	)		(193,500	)		(2,225,400	)
Assets		7,137,200		5,101,300			809,600			13,048,100
Long-Lived Asset Expenditures		-		11,700			-			11,700
Depreciation and Amortization		20,700		167,500			-			188,200

Nine Months Ended September 30, 2024:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	6,765,900	$	1,134,000		$	-		$	7,899,900
Foreign Sales		1,779,100		648,100						2,427,200
Income (Loss) From Operations		546,000		(4,094,700	)		(1,135,600	)		(4,684,300	)
Assets		6,144,600		4,697,900			2,464,300			13,306,800
Long-Lived Asset Expenditures		72,800		3,200			-			76,000
Depreciation and Amortization		64,700		500,700			-			565,400

Nine Months Ended September 30, 2023:	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate And Other			Consolidated
Revenues	$	7,357,800	$	1,015,600		$	-		$	8,373,400
Foreign Sales		2,204,800		478,700						2,683,500
Income (Loss) From Operations		555,200		(5,972,600	)		(1,501,800	)		(6,919,200	)
Assets		7,137,200		5,101,300			809,600			13,048,100
Long-Lived Asset Expenditures		25,200		92,700			-			117,900
Depreciation and Amortization		64,400		502,300			-			566,700

Schedule Of Reconciliation Of The Company's consolidated Segment Incomed Loss

For the three months ended September 30, 2024	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	258,700	$	(1,200,000	)	$	(317,300	)	$	(1,258,600	)
Other income, net		2,100		11,400			24,900			38,400
Interest income		-					40,100			40,100
Total other income, net		2,100		11,400			65,000			78,500
Income (Loss) from operations before discontinued operations and income taxes	$	260,800	$	(1,188,600	)	$	(252,300	)	$	(1,180,100	)
For the three months ended September 30, 2023	Benchtop Laboratory Equipment		Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	73,600	$	(2,105,500	)	$	(193,500	)	$	(2,225,400	)
Other income (expense), net		5,300		(1,800	)		1,800			5,300
Interest income		-		-			19,000			19,000
Total other income (expense), net		5,300		(1,800	)		20,800			24,300
Income (Loss) from operations before discontinued operations and income taxes	$	78,900	$	(2,107,300	)	$	(172,700	)	$	(2,201,100	)

For the nine months ended September 30, 2024	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	546,000		$	(4,094,700	)	$	(1,135,600	)	$	(4,684,300	)
Other income (expense), net		(5,100	)		22,500			14,700			32,100
Interest income		-			-			136,900			136,900
Total other income (expense), net		(5,100	)		22,500			151,600			169,000
Income (Loss) from operations before discontinued operations and income taxes	$	540,900		$	(4,072,200	)	$	(984,000	)	$	(4,515,300	)
For the nine months ended September 30, 2023	Benchtop Laboratory Equipment			Bioprocessing Systems			Corporate			Consolidated
Income (Loss) from Operations	$	555,200		$	(5,972,600	)	$	(1,501,800	)	$	(6,919,200	)
Other income, net		7,700			9,300			78,700			95,700
Interest income		-			-			65,400			65,400
Total other income, net		7,700			9,300			144,100			161,100
Income (Loss) from operations before discontinued operations and income taxes	$	562,900		$	(5,963,300	)	$	(1,357,700	)	$	(6,758,100	)